Published in Vopr Med Khim on October 29, 1987
The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate. Cardiovasc Hematol Agents Med Chem (2008) 1.28
What is vinculin needed for in platelets? J Thromb Haemost (2010) 0.90
[The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results]. Ter Arkh (2012) 0.81
[Fibronectin receptors on the surfaces of alveolar macrophages]. Tsitologiia (1983) 0.76
[Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease]. Eksp Klin Gastroenterol (2014) 0.76
Cell microvesicles during experimental endotoxemia. Bull Exp Biol Med (2006) 0.76
Effect of blood microparticles on the kinetics of polymerization and enzymatic hydrolysis of fibrin. Dokl Biochem Biophys (2015) 0.76
Additional considerations on measuring the binding strength of single ligand-receptor pairs on cells: reply to a rebuttal. J Thromb Haemost (2004) 0.75
Measuring the binding strength of single ligand-receptor pairs on cells: rebuttal. J Thromb Haemost (2004) 0.75
[Role of the Hageman factor in regulation of blood coagulability]. Fiziol Zh SSSR Im I M Sechenova (1972) 0.75
[Circulation of tissue thromboplastin in the blood]. Fiziol Zh SSSR Im I M Sechenova (1984) 0.75
[The determination of tissue thromboplastin activity in cells]. Lab Delo (1991) 0.75
[Effect of Glycine max lectin on the interaction of prothrombin and erythrocytes]. Vopr Med Khim (1997) 0.75
[Continuous blood coagulation in the body]. Probl Gematol Pereliv Krovi (1974) 0.75
[Distribution of thromboplastic and 5'-nucleotidase activity in human liver]. Vopr Med Khim (1983) 0.75
[Interaction of lectins with tissue thromboplastin]. Gematol Transfuziol (1990) 0.75
[Contact phase of blood coagulation and formation of thrombi in the blood vessel prosthesis]. Eksp Khir Anesteziol (1975) 0.75
[Effect of immobilized noradrenaline on the contact phase of blood coagulation]. Vopr Med Khim (1977) 0.75
[Effect of enzymes involved in the contact phase of blood clotting on the functional activity of neutrophils related to phagocytosis]. Biull Eksp Biol Med (1978) 0.75
[Matrix hypotheses of the enzymatic cascade in blood coagulation]. Probl Gematol Pereliv Krovi (1980) 0.75
[Effects of hemosplenic perfusion on the state of humoral immunity in suppurative-septic complications in emergency abdominal surgery]. Vestn Khir Im I I Grek (2000) 0.75
[Interaction of human prothrombin with tissue thromboplastin]. Biokhimiia (1989) 0.75
[Intestinal microflora and concomitant gastrointestinal diseases in patients with chronic hepatitis B and C]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.75
[Specificity and sensitivity of paracoagulation tests]. Lab Delo (1980) 0.75
[Electrophoresis of the plasminogen activators]. Lab Delo (1973) 0.75
[Biochemical basis of a fibrinogen B test (a discussion of V. K. Peters' article, "The Quantitative Determination of Fibrinogen B")]. Lab Delo (1980) 0.75
[The expression and degradation of tissue thromboplastin]. Fiziol Zh SSSR Im I M Sechenova (1988) 0.75
[Plasma fibronectin in complicated forms of respiratory viral infections in young children]. Pediatriia (1990) 0.75
[Diagnosis of thromboplastinemia in myocardial infarct]. Ter Arkh (1981) 0.75
[The role of lipid peroxidation in the process of thermal inactivation of tissue thromboplastin]. Vopr Med Khim (1987) 0.75
[General recommendations for laboratory work in studying blood coagulability]. Klin Lab Diagn (1998) 0.75
[Nature of fibrinogen B-soluble fibrin monomer complexes precipitable by ethanol and 2-naphthol]. Biokhimiia (1980) 0.75
[The role of plasma fibronectin in the pathogenesis of post- aggressive conditions]. Gematol Transfuziol (1992) 0.75
[Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X]. Biokhimiia (1984) 0.75
[Quantitative and qualitative changes in the fibronectin level in rheumatoid arthritis]. Ter Arkh (1988) 0.75
[Participation of alveolar macrophages in the catabolism of fibrinogen and fibrin]. Biull Eksp Biol Med (1989) 0.75
[Clinical importance of fibronectin research in rheumatoid arthritis]. Revmatologiia (Mosk) (1989) 0.75
[Hemocoagulation properties of the vascular wall in dicoumarin induced hemorrhagic diathesis]. Patol Fiziol Eksp Ter (1972) 0.75
[Studies on the glycopeptides of canine prothrombin]. Biokhimiia (1977) 0.75
[Distribution and inactivation of tissue thromboplastin in the body]. Gematol Transfuziol (1988) 0.75
[Effect of exogenous fibronectin on the healing of skin wounds as evidenced by tensiometric data]. Biull Eksp Biol Med (1987) 0.75
[Effect of modifications of the protein moiety of thromboplastin (factor III) on its activity]. Biokhimiia (1981) 0.75
[Clinical significance of fibronectin level in the assessment of severity and prognosis of acute diseases of the respiratory tract in children]. Pediatriia (1988) 0.75
[The rate of physiological fibrinolysis in the mesenteric and renal vessels of rabbits]. Fiziol Zh Im I M Sechenova (1996) 0.75
Effect of radiation on prothrombin interactions with cell membrane fragments. Bull Exp Biol Med (2002) 0.75
[Role of vascular and thrombocyte membranes in hypercoagulemia]. Kardiologiia (1974) 0.75
[Noncoagulative catabolism of fibrinogen]. Vopr Med Khim (1975) 0.75
[Effect of immobilized noradrenaline on human plasma arginine esterase activated by factor XII]. Biokhimiia (1977) 0.75
[Biological effects of Gelatinol during artificial circulation]. Klin Med (Mosk) (1990) 0.75
[Device for illuminating objects in transmitted light for the purpose of photography]. Lab Delo (1980) 0.75
[A rare case of congenital hypodysfibrinogenemia]. Gematol Transfuziol (1985) 0.75
[Effect of lysozyme suppression of factor XII activation on postadrenaline hypercoagulation]. Fiziol Zh SSSR Im I M Sechenova (1980) 0.75
[The effect of fibronectin preparations on the chemiluminescence of neutrophils]. Vopr Med Khim (1990) 0.75
[Molecular weight of human native factor XII (Hageman factor)]. Dokl Akad Nauk SSSR (1974) 0.75
[Effect of a factor XII inhibitor isolated from kernels of corn on the cold activation of factor VII in blood plasma]. Gematol Transfuziol (1986) 0.75
[The effect of lysozyme, ribonuclease and cytochrome C on the activation of one of the blood coagulation factors--the Hageman factor--by adrenaline]. Ukr Biokhim Zh (1973) 0.75
[Functional concept of the initiation of blood coagulation by cell membranes]. Gematol Transfuziol (1991) 0.75
[Role of Kupffer cells and hepatocytes in fibrinogen catabolism]. Vopr Med Khim (1982) 0.75
[Interaction of human thrombin I fragment, prethrombin I, and alpha-thrombin with tissue thromboplastin]. Biokhimiia (1992) 0.75
[A method of determining the concentration of biologically active fibronectin]. Lab Delo (1989) 0.75
[Characteristics of proteins precipitated from pathologic human blood plasma with ethanol and beta-naphthol]. Vestn Akad Med Nauk SSSR (1981) 0.75
[Interaction of prothrombin with erythrocytes and alveolar macrophages]. Gematol Transfuziol (1994) 0.75
[Role of the reticuloendothelial system in the catabolism of fibrinogen]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.75
[Functional activity of endotoxin binding factors in chronic viral hepatitis B and C]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.75
[Blood coagulating properties of immobilized proteases]. Vopr Med Khim (1977) 0.75
[Mechanism of nonenzymatic fibrinolysis]. Vopr Med Khim (1981) 0.75
[Effect of fibronectin on fibrinogen conversion into fibrin]. Biokhimiia (1988) 0.75
[Hemocoagulation and fibrinolytic properties of alkaline phosphatase]. Probl Gematol Pereliv Krovi (1975) 0.75
New evidence for the activation of factor XII by epinephrine. Thromb Res (1976) 0.75
[Reactions initiating blood coagulation]. Ukr Biokhim Zh (1978) (1983) 0.75
[The spectrum and activity of urinary Ig-proteinases as a marker of chronic pyelonephritis]. Ter Arkh (2004) 0.75
[Interaction of fibronectin with polymorphonuclear leukocytes normally and in anaphylaxis]. Biull Eksp Biol Med (1986) 0.75
Characterization of the ethanol and beta-naphthol precipitable proteins from pathological human plasma. Thromb Res (1981) 0.75
[Fractional composition of fibrinogen B]. Lab Delo (1977) 0.75
[Fibronectin and fibronectin receptors on the surfaces of polymorphonuclear leukocytes]. Biull Eksp Biol Med (1982) 0.75
[Interaction of alveolar macrophages with fibronectin during sensitization and anaphylactic shock]. Biull Eksp Biol Med (1985) 0.75
[Irreversible pH-denaturation of tissue thromboplastin]. Vopr Med Khim (1992) 0.75
[Carbohydrate composition and properties of dog prothrombin]. Zh Evol Biokhim Fiziol (1974) 0.75
[Effects of fibronectin instillation on reparative regeneration of the corneal tissue (an experimental study)]. Vestn Oftalmol (1990) 0.75
[Clinical and diagnostic importance of the evaluation of the Ig proteases activity in children with intestinal dysbacteriosis]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.75
[Use of immobilized proteinases for purification of sheep smallpox virus]. Biokhimiia (1979) 0.75
[Adrenaline-induced release from thrombocytes of beta-lipoprotein, alkaline phosphatase and 5'-nucleotidase]. Biull Eksp Biol Med (1976) 0.75
[Physiological intravascular activation of blood coagulation]. Gematol Transfuziol (1983) 0.75
Effect of lupus anticoagulant on the interaction of prothrombin with platelets. Bull Exp Biol Med (2004) 0.75
[Mechanism of the effect of immobilized noradrenaline on the contact phase of blood coagulation]. Vopr Med Khim (1979) 0.75
[Characteristics of antitoxic and antibacterial immune response in nontoxic forms of oropharyngeal diphtheria]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.75
[Interaction of human factor X with thromboplastin]. Biomed Khim (2005) 0.75
[Determination of C-terminal amino acid content in dog prothrombin]. Ukr Biokhim Zh (1978) (1978) 0.75
[Canine fibrinogen glycopeptides]. Biokhimiia (1980) 0.75
[Circulation of soluble fibrin monomer in the body]. Vopr Med Khim (1978) 0.75
[Dynamics of 5'-nucleotidase activity in the blood plasma in experimental myocardial infarct]. Kardiologiia (1981) 0.75